Why these huge costs ?   A lot of the problem is the sheer complexity of making a new drug , plus , of course , the    burdens of taxes andregulation —   more on that later .    Yet in the meantime , American pharma companies know that their main chance to recoup their investment is in American pharma companies US market , and American pharma companies that ’s what market do —   hence the high prices for American pharma companies .   